Fujian Cosunter Pharmaceutical Co Ltd (300436) - Total Liabilities
Based on the latest financial reports, Fujian Cosunter Pharmaceutical Co Ltd (300436) has total liabilities worth CN¥1.10 Billion CNY (≈ $160.64 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Fujian Cosunter Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Fujian Cosunter Pharmaceutical Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Fujian Cosunter Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Fujian Cosunter Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Fujian Cosunter Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Fujian Cosunter Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Autohome Inc ADR
F:8AHB
|
Germany | €4.01 Billion |
|
Ningbo Jifeng Auto Parts Co
SHG:603997
|
China | CN¥16.81 Billion |
|
NFI Group Inc
TO:NFI
|
Canada | CA$2.61 Billion |
|
China Southern Airlines Company Limited
F:ZNHH
|
Germany | €299.35 Billion |
|
Navitas Semiconductor Corp
NASDAQ:NVTS
|
USA | $59.22 Million |
|
Íslandsbanki hf.
IC:ISB
|
Iceland | Ikr1.47 Trillion |
|
Feng Tay Enterprises Co Ltd
TW:9910
|
Taiwan | NT$24.87 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Fujian Cosunter Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300436 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.78 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fujian Cosunter Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fujian Cosunter Pharmaceutical Co Ltd (2011–2025)
The table below shows the annual total liabilities of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.05 Billion ≈ $154.26 Million |
+1.17% |
| 2024-12-31 | CN¥1.04 Billion ≈ $152.48 Million |
-0.31% |
| 2023-12-31 | CN¥1.05 Billion ≈ $152.95 Million |
+93.84% |
| 2022-12-31 | CN¥539.22 Million ≈ $78.91 Million |
+35.85% |
| 2021-12-31 | CN¥396.92 Million ≈ $58.08 Million |
-6.41% |
| 2020-12-31 | CN¥424.10 Million ≈ $62.06 Million |
+31.50% |
| 2019-12-31 | CN¥322.51 Million ≈ $47.19 Million |
+10.32% |
| 2018-12-31 | CN¥292.33 Million ≈ $42.78 Million |
+58.51% |
| 2017-12-31 | CN¥184.42 Million ≈ $26.99 Million |
+24.35% |
| 2016-12-31 | CN¥148.30 Million ≈ $21.70 Million |
+81.96% |
| 2015-12-31 | CN¥81.50 Million ≈ $11.93 Million |
+21.21% |
| 2014-12-31 | CN¥67.24 Million ≈ $9.84 Million |
+23.56% |
| 2013-12-31 | CN¥54.42 Million ≈ $7.96 Million |
+33.33% |
| 2012-12-31 | CN¥40.82 Million ≈ $5.97 Million |
-6.93% |
| 2011-12-31 | CN¥43.86 Million ≈ $6.42 Million |
-- |
About Fujian Cosunter Pharmaceutical Co Ltd
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men's health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzh… Read more